NO20034269L - Use of compounds with the biological activity of vasoactive intestinal peptide for the treatment of chronic obstructive pulmonary disease - Google Patents

Use of compounds with the biological activity of vasoactive intestinal peptide for the treatment of chronic obstructive pulmonary disease

Info

Publication number: NO20034269L
Authority: NO; Norway
Prior art keywords: compounds; treatment; biological activity; pulmonary disease; chronic obstructive
Prior art date: 2002-01-26

Application number

NO20034269A

Other languages

Norwegian (no)

Other versions

NO20034269D0 (en

Inventor

Dorian Bevec

Original Assignee

Mondobiotech Lab Anstalt

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-01-26

Filing date

2003-09-24

Publication date

2003-11-26

2003-09-24 Application filed by Mondobiotech Lab Anstalt filed Critical Mondobiotech Lab Anstalt

2003-09-24 Publication of NO20034269D0 publication Critical patent/NO20034269D0/en

2003-11-26 Publication of NO20034269L publication Critical patent/NO20034269L/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2278—Vasoactive intestinal peptide [VIP]; Related peptides (e.g. Exendin)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Pulmonology (AREA)
Vascular Medicine (AREA)
Endocrinology (AREA)
Zoology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

NO20034269A 2002-01-26 2003-09-24 Use of compounds with the biological activity of vasoactive intestinal peptide for the treatment of chronic obstructive pulmonary disease NO20034269L (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP02001839		2002-01-26
PCT/CH2003/000056 WO2003061680A2 (en)	2002-01-26	2003-01-23	Use of compounds having the biological activity of vasoactive intestinal peptide for the treatment of chronic obstructive pulmonary disease

Publications (2)

Publication Number	Publication Date
NO20034269D0 NO20034269D0 (en)	2003-09-24
NO20034269L true NO20034269L (en)	2003-11-26

Family

ID=27589068

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20034269A NO20034269L (en)	2002-01-26	2003-09-24	Use of compounds with the biological activity of vasoactive intestinal peptide for the treatment of chronic obstructive pulmonary disease

Country Status (5)

Country	Link
EP (1)	EP1468021A2 (en)
BR (1)	BR0302832A (en)
CA (1)	CA2472270A1 (en)
NO (1)	NO20034269L (en)
WO (1)	WO2003061680A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2532135A1 (en)	2003-07-14	2005-01-20	Mondobiotech Laboratories Anstalt	Biologically active substance of a vasoactive intestinal peptide for treating interstitial lung infections
WO2005014030A1 (en) *	2003-07-24	2005-02-17	Lutz-Henning Block	Method for treating lung diseases associated with ventilation-perfusion mismatches
US9006181B2 (en) *	2004-07-21	2015-04-14	The Administrators Of The Tulane Educational Fund	Treatment of renal dysfunction and multiple myeloma using PACAP compounds
CN102883739B (en)	2009-11-02	2015-11-25	图兰恩教育基金管理人	Analogs of pituitary adenylate cyclase-activating polypeptide (PACAP) and methods of their use
EP3583933A1 (en)	2018-06-20	2019-12-25	Albert-Ludwigs-Universität Freiburg	Administration of aviptadil by inhalation to treat chronic beryllium disease
BR112021022170A2 (en)	2019-05-07	2021-12-21	Advita Lifescience Gmbh	Vasoactive intestinal peptide (VIP) for use in the treatment of drug-induced pneumonitis
EP4232073B1 (en)	2020-12-04	2024-05-01	Centurion Ilac Sanayi Ve Ticaret Anonim Sirketi	New dosage regimen for inhaled vasoactive intestinal polypeptide
CA3214539A1 (en) *	2021-04-20	2022-10-27	Dorian Bevec	Use of aviptadil alone or in combination with alpha lipoic acid as a therapeutic medicament for post-viral infection syndrome

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5612314A (en) *	1995-04-21	1997-03-18	Brigham & Women's Hospital	Nitrosylated neuropeptides
GB9818548D0 (en) *	1998-08-25	1998-10-21	Microbiological Res Authority	Treatment of mucas hypersecretion
CN1487952A (en) *	2000-11-28	2004-04-07	�ɶ��＼��ʵ��	Compounds with biological activity of vasoactive intestinal peptide for treating pulmonary and arteriolar hypertension

2003
- 2003-01-23 CA CA002472270A patent/CA2472270A1/en not_active Abandoned
- 2003-01-23 BR BR0302832-1A patent/BR0302832A/en not_active Application Discontinuation
- 2003-01-23 EP EP03731651A patent/EP1468021A2/en not_active Withdrawn
- 2003-01-23 WO PCT/CH2003/000056 patent/WO2003061680A2/en not_active Ceased
- 2003-09-24 NO NO20034269A patent/NO20034269L/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
WO2003061680A2 (en)	2003-07-31
CA2472270A1 (en)	2003-07-31
BR0302832A (en)	2004-04-27
NO20034269D0 (en)	2003-09-24
WO2003061680A9 (en)	2004-06-03
EP1468021A2 (en)	2004-10-20
WO2003061680A3 (en)	2003-11-13

Similar Documents

Publication	Publication Date	Title
ATE430569T1 (en)	2009-05-15	NEW DRUGS FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE LUNG DISEASE
NO20034590D0 (en)	2003-10-13	Procedures for the treatment of vascular disease
NO20053077D0 (en)	2005-06-23	Therapeutic formulations for the treatment of beta-amyloid-related diseases.
DE60320007D1 (en)	2008-05-08	PHENETHANOLAMINE DERIVATIVES FOR THE TREATMENT OF RESPIRATORY DISEASES
ATE484494T1 (en)	2010-10-15	SUBSTITUTED INDOLE DERIVATIVES FOR A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF RESPIRATORY DISEASES
DE60317887D1 (en)	2008-01-17	SYSTEM FOR THE ADMINISTRATION OF THERAPEUTIC SUBSTANCES
HUE050998T2 (en)	2021-01-28	Drugs for the treatment of fibrotic diseases
IL173909A0 (en)	2006-07-05	Use of modified cyclosporins for the treatment of hcv disorders
DE60322451D1 (en)	2008-09-04	4-tetrazolyl-4-phenylpiperidine derivatives for the treatment of pain
EA200500098A1 (en)	2005-08-25	MEDICINE AND METHOD FOR THE TREATMENT OF THE PATHOLOGICAL SYNDROME
DE602005017636D1 (en)	2009-12-24	NEW HYDANTINE DERIVATIVES FOR THE TREATMENT OF OBSTRUCTIVE RESPIRATORY DISEASES
PL372695A1 (en)	2005-07-25	Medicament for the treatment of diseases requiring inhibition or a reduction in the activity of ph value-regulating bicarbonate transporter proteins
NO20050569D0 (en)	2005-02-02	Procedure for the treatment of severe heart failure and drug for this
GB0410399D0 (en)	2004-06-16	The treatment of respiratory disease
GB0410398D0 (en)	2004-06-16	The treatment of respiratory disease
NO20034269D0 (en)	2003-09-24	Use of compounds with the biological activity of vasoactive intestinal peptide for the treatment of chronic obstructive pulmonary disease
IS7163A (en)	2004-02-26	Methods for the treatment of pulmonary disease
EP1494696A4 (en)	2006-01-25	TREATMENT OF LUNG DISEASES
EE200300328A (en)	2003-10-15	Use of IL-18 inhibitors for the treatment and / or prevention of heart disease
DK1553950T3 (en)	2007-10-15	Therapeutic treatment
NO20012831D0 (en)	2001-06-08	Diazepinoindoles for the treatment of chronic obstructive pulmonary disease
NO20052814D0 (en)	2005-06-10	Cytomodulatory peptides for the treatment of interstitial cystitis
ATE491442T1 (en)	2011-01-15	1-PHENYL-2- DIMETHYLAMINOMETHYLCYCLOHEXANE COMPOUNDS FOR THE THERAPY OF DEPRESSIVE SYMPTOMS, PAIN AND INCONTINENCE
ATE517877T1 (en)	2011-08-15	NEW DRUGS FOR THE TREATMENT OF RESPIRATORY DISEASES
EP1565055A4 (en)	2010-12-29	COMPOUNDS FOR THE TREATMENT OF TOBACCO AND WEANING

Legal Events

Date	Code	Title	Description
2005-09-26	FC2A	Withdrawal, rejection or dismissal of laid open patent application